Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04849780 · ClinicalTrials.gov registry record · NA

Evaluation of Dryness in a Silicone Hydrogel Daily Disposable Contact Lens

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
95
Enrollment target
9
Study locations

NCT04849780 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 95 participants, below the 135-participant average among 20 other Visual Acuity trials with a reported enrollment target (30% lower). The trial reports 9 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04849780, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
9
Study locations

Study Summary

This is a multi-site, randomized, bilateral, dispensing, parallel design study with two arms to evaluate contact lens related dry eye symptoms and subjective comfort.

Conditions Studied

Interventions

  • DEVICE ACUVUE Oasys 1-Day
  • DEVICE Habitual Lens

Study Locations (9)

Florida

  • Vue Optical Boutique - Jacksonville
  • Sabal Eye Care - Longwood
  • Maitland Vision Center - Maitland

Kansas

  • Kannarr Eye Care - Pittsburg

New York

  • Sacco Eye Group - Vestal

Ohio

  • Procare Vision Centers - Granville

Rhode Island

  • Dr. David Ferris & Associates - Warwick

Tennessee

  • Optometry Group Pllc - Memphis

Texas

  • Tyler Eye Associates - Tyler

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2021-04-17
Est. Completion 2021-08-12
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT04849780

The ClinicalTrials.gov registry entry for NCT04849780 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 20 other Visual Acuity trials with a reported enrollment target (30% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which ACUVUE Oasys 1-Day is the first listed.

NCT04849780 reports 9 study locations spanning 7 distinct geographic areas - top geographies include Florida, Kansas, New York.

Frequently Asked Questions

What is clinical trial NCT04849780 about?

NCT04849780 is a clinical study titled "Evaluation of Dryness in a Silicone Hydrogel Daily Disposable Contact Lens". This is a multi-site, randomized, bilateral, dispensing, parallel design study with two arms to evaluate contact lens related dry eye symptoms and subjective comfort.

What is the current status of trial NCT04849780?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2021-04-17. Estimated completion is 2021-08-12.

What conditions does trial NCT04849780 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT04849780?

The interventions under investigation include: ACUVUE Oasys 1-Day (DEVICE), Habitual Lens (DEVICE).

Who is sponsoring clinical trial NCT04849780?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04849780 being conducted?

This trial has 9 study locations across Florida, Kansas, New York, Ohio, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.